Home/Filings/4/A/0001209191-05-004625
4/A//SEC Filing

MANTELLE JUAN A 4/A

Accession 0001209191-05-004625

CIK 0000815838other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 3:22 PM ET

Size

7.9 KB

Accession

0001209191-05-004625

Insider Transaction Report

Form 4/AAmended
Period: 2004-09-08
MANTELLE JUAN A
VP and Chief Technical Officer
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2004-09-081,849652 total
    Exercise: $8.67Exp: 2005-01-21Common Stock (1,849 underlying)
  • Exercise/Conversion

    Common Stock ($.0001 Par Value)

    2004-09-08$8.67/sh+1,849$16,0318,549 total
Footnotes (2)
  • [F1]10% exercisable after 1/21/1999; 20% exercisable after 1/21/2000; 20% exercisable after 1/21/2001; 25% exercisable after 1/21/2002; 25% exercisable after 1/21/2003. The reporting person has transferred 2,499 of such options to his ex-wife pursuant to a domestic relations order.
  • [F2]This amended Form 4 is filed to report the correct expiration date of the stock options in this line item. Other than this transaction, the remainder of the original report has not been restated in this amended Form 4.

Issuer

NOVEN PHARMACEUTICALS INC

CIK 0000815838

Entity typeother

Related Parties

1
  • filerCIK 0001224098

Filing Metadata

Form type
4/A
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 3:22 PM ET
Size
7.9 KB